HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined hepatitis B vaccines.

Abstract
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed. Data on the safety, immunogenicity, and European licensing status and availability of haxavalent vaccines combining hepatitis B (HepB), Haemophilus influenza type b (Hib), diphtheria, tetanus, and pertussis (acellular) (DTPa), and inactivated poliovirus (IPV) antigens were presented. Finally, the impact of the availability of combined hepatitis B vaccines on hepatitis B immunisation programmes in Europe were examined and the added value of combined hepatitis B vaccines globally was estimated.
AuthorsDavid FitzSimons, Guido François, Nedret Emiroğlu, Pierre Van Damme
JournalVaccine (Vaccine) Vol. 21 Issue 13-14 Pg. 1310-6 (Mar 28 2003) ISSN: 0264-410X [Print] Netherlands
PMID12615425 (Publication Type: Journal Article)
Chemical References
  • Hepatitis B Vaccines
  • Vaccines, Combined
Topics
  • Clinical Trials as Topic
  • Drug and Narcotic Control
  • Hepatitis B Vaccines (economics, immunology)
  • Humans
  • Immunization Schedule
  • Licensure
  • Vaccines, Combined (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: